Patents Assigned to GENNEXT TECHNOLOGIES, INC.
  • Patent number: 12263477
    Abstract: Systems and methods of in vivo and in vitro radical protein foot-printing using an opto-fluidic array are presented. These teachings may be used to, for example, study three-dimensional protein structure or bio-kinetics. Radical dosimetry including an optional intrinsic standard is used. Real-time feedback based on an internal standard provides comparability between different experiments and in vivo and in vitro analysis results in data that is representative of actual biological conditions.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: April 1, 2025
    Assignee: GENNEXT TECHNOLOGIES, INC.
    Inventors: Scot Randy Weinberger, Robert Wallace Egan, Jeffrey Johnathan Persoff, Emily Elizabeth Chea, Tan Huu Bui, David Allan Holman
  • Patent number: 12016688
    Abstract: Systems and methods of in vivo hydroxyl radical protein foot-printing are presented. These teachings may be used to, for example, study three-dimensional protein structure or bio-kinetics. Radical Dosimetry including an optional intrinsic standard is used on isolated intact cells. Real-time feedback based on an internal standard provides comparability between different experiments and in vivo analysis results in data that is representative of actual biological conditions.
    Type: Grant
    Filed: August 25, 2021
    Date of Patent: June 25, 2024
    Assignee: GENNEXT TECHNOLOGIES, INC.
    Inventor: Scot Randy Weinberger
  • Patent number: 12013400
    Abstract: Flash Photo-Oxidation Device and Higher Order Structural Analysis is employed for higher order structural analysis of biomolecules. Biomolecular higher order structure (HOS) results from the confounded superimposition of a biomolecule's secondary, tertiary, and quaternary structure and defines the manner in which a biomolecule presents itself and interacts with other biomolecules in living systems. A rapidly growing class of therapeutic drugs, known as biotherapeutics, comprises a variety of proteins, whose therapeutic properties are inherently linked and dependent upon their HOS. As such, HOS analysis of biotherapeutics is an important analytical requirement in the biopharmaceutical industry.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: June 18, 2024
    Assignee: GENNEXT TECHNOLOGIES, INC.
    Inventors: Scot Randy Weinberger, Ronald Carl Orlando, Joshua Shane Sharp, Robert Wallace Egan, Jeffrey Jonathan Persoff
  • Patent number: 12013401
    Abstract: Flash Photo-Oxidation Device and Higher Order Structural Analysis is employed for higher order structural analysis of biomolecules. Biomolecular higher order structure (HOS) results from the confounded superimposition of a biomolecule's secondary, tertiary, and quaternary structure and defines the manner in which a biomolecule presents itself and interacts with other biomolecules in living systems. A rapidly growing class of therapeutic drugs, known as biotherapeutics, comprises a variety of proteins, whose therapeutic properties are inherently linked and dependent upon their HOS. As such, HOS analysis of biotherapeutics is an important analytical requirement in the biopharmaceutical industry.
    Type: Grant
    Filed: May 2, 2023
    Date of Patent: June 18, 2024
    Assignee: GENNEXT TECHNOLOGIES, INC.
    Inventors: Scot Randy Weinberger, Ronald Carl Orlando, Joshua Shane Sharp, Robert Wallace Egan, Jeffrey Jonathan Persoff
  • Patent number: 10816468
    Abstract: Flash Photo-Oxidation Device and Higher Order Structural Analysis is employed for higher order structural analysis of biomolecules. Biomolecular higher order structure (HOS) results from the confounded superimposition of a biomolecule's secondary, tertiary, and quaternary structure and defines the manner in which a biomolecule presents itself and interacts with other biomolecules in living systems. A rapidly growing class of therapeutic drugs, known as biotherapeutics, comprises a variety of proteins, whose therapeutic properties are inherently linked and dependent upon their HOS. As such, HOS analysis of biotherapeutics is an important analytical requirement in the biopharmaceutical industry.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: October 27, 2020
    Assignee: GENNEXT TECHNOLOGIES, INC.
    Inventors: Scot Randy Weinberger, Ronald Carl Orlando, Joshua Shane Sharp, Robert Wallace Egan, Jeffrey Jonathan Persoff